مقاله انگلیسی تمایل والدین برای واکسیناسیون دختر خود در برابر ویروس پاپیلومای انسانی
ترجمه نشده

مقاله انگلیسی تمایل والدین برای واکسیناسیون دختر خود در برابر ویروس پاپیلومای انسانی

عنوان فارسی مقاله: تمایل والدین برای واکسیناسیون دختر خود در برابر ویروس پاپیلومای انسانی و عوامل مرتبط با آن در منطقه بنچ-شکو ، جنوب غربی اتیوپی
عنوان انگلیسی مقاله: Parents willingness to vaccinate their daughter against human papilloma virus and its associated factors in Bench-Sheko zone, southwest Ethiopia
مجله/کنفرانس: هلیون - Heliyon
رشته های تحصیلی مرتبط: پزشکی
گرایش های تحصیلی مرتبط: پزشکی کودکان، ایمونولوژی
کلمات کلیدی فارسی: تمایل والدین ، واکسن HPV ، اتیوپی
کلمات کلیدی انگلیسی: Parental willingness, HPV vaccine, Ethiopia
نوع نگارش مقاله: مقاله پژوهشی (Research Article)
شناسه دیجیتال (DOI): https://doi.org/10.1016/j.heliyon.2021.e07051
دانشگاه: Mizan Tepi University, Ethiopia
صفحات مقاله انگلیسی: 5
ناشر: الزویر - Elsevier
نوع ارائه مقاله: ژورنال
نوع مقاله: ISI
سال انتشار مقاله: 2021
ایمپکت فاکتور: 2.850 در سال 2020
شاخص H_index: 28 در سال 2021
شاخص SJR: 0.455 در سال 2020
شناسه ISSN: 2405-8440
شاخص Quartile (چارک): Q1 در سال 2020
فرمت مقاله انگلیسی: PDF
وضعیت ترجمه: ترجمه نشده است
قیمت مقاله انگلیسی: رایگان
آیا این مقاله بیس است: بله
آیا این مقاله مدل مفهومی دارد: دارد
آیا این مقاله پرسشنامه دارد: ندارد
آیا این مقاله متغیر دارد: دارد
کد محصول: E15487
رفرنس: دارای رفرنس در داخل متن و انتهای مقاله
نوع رفرنس دهی: vancouver
فهرست مطالب (انگلیسی)

Abstract

Keywords

1. Introduction

2. Methods and materials

3. Result

4. Discussion

5. Conclusion and recommendations

Declarations

Acknowledgements

References

بخشی از مقاله (انگلیسی)

Abstract

Background
In Ethiopia, the human papillomavirus vaccine has been introduced since 2018. Since the vaccination program targets girls age 9–13, the success of vaccination depends on the parental decision and their willingness to vaccinate their daughters. Therefore, a study on parental willingness to vaccinate their daughter and factors associated is needed.

Objective
To assess parent's willingness to vaccinate their daughter against the human papillomavirus and its associated factors in Bench-Sheko Zone, southwest Ethiopia.

Methods
A community-based cross-sectional study was conducted among 502 participants in Bench-Sheko Zone, southwest Ethiopia. The participants were selected using a systematic random sampling method. Frequency tables, mean and standard deviation were used to summarize the data. A binary logistic regression using bivariate and multivariable logistic regression analysis was used to identify factors associated with parental willingness to vaccinate their daughter. The level of significance was declared at P-value < 0.05.

Results
Of the 502 participants interviewed, 399 (79.5%), 95% CI (76%, 83%) of parents were willing to vaccinate their daughter. The study found that primary education and above (AOR = 2.9, 95% CI [1.79, 4.95]), having good knowledge (AOR = 2.1, 95% CI [1.15, 4.10]) and positive attitude (AOR = 2, 95% CI [1.30, 3.41]) were significantly associated with parental willingness to vaccinate their daughter.

Conclusion
This study found that there was a high parental willingness to vaccinate their daughter against the human papillomavirus in the study area. Primary education and above, having good knowledge and positive attitude were factors associated with parental willingness to vaccinate their daughter. Therefore, providing health information's regarding human papillomavirus vaccination with emphasis to raise community awareness should be designed especially less educated parents need to be targeted.

 

1. Introduction

Cervical cancer is the fourth most common cancer diagnosed among women worldwide [[1]]. More than 80% of the cases are in developing countries [[1]]. In Ethiopia, cervical cancer becomes the second leading cause of cancer death [[1]]. Cervical cancer prevention programs such as HPV vaccination and cytology-based cervical cancer screening programs decreased cervical cancer incidence in developed countries [[2]]. However, in developing countries, lack of access to effective screening and low screening coverage, poverty, low education, and life in rural areas [[3], [4]] coupled with a high incidence of HPV 16 and 18 infections [[5]] increases cervical cancer incidence.

Persistent human papillomavirus (HPV) infection, a sexually transmitted disease, is identified as the necessary cause of cervical cancer particularly HPV 16, 18, and 31 serotypes [[6], [7]]. More than 80% of sexually active women are infected by HPV at least once during their lifetime [[8]]. In response to this, the world health organization develops comprehensive strategies for the prevention and control of cervical cancer including HPV vaccination as the primary prevention method for cervical cancer [[9]]. Three HPV vaccines namely bivalent (Cervarix, GlaxoSmithKline), quadrivalent (Gardasil, Merck), and nonavalent (Gardasil, Merck) vaccines are currently available, and have proven effective at protecting against HPV 16 and HPV 18 infections [[10]]. which are currently approved for vaccination in developing countries by WHO [[11]]. In Ethiopia, HPV vaccine with the support of the Global Alliance for Vaccine and Immunization (GAVI) has been introduced since 2018 being delivered through a school-based approach [[12]] as Ethiopia fulfilled the GAVI Alliances eligibility criteria for HPV vaccination support [[13]]. WHO recommends the vaccination to girls of age 9–13 years old [[14]].